Kimberly-Clark Is Buying Tylenol Maker Kenvue for Nearly $49B. Here's What You Need to KnowInvestopedia • 11/03/25
Kimberly-Clark buys Tylenol maker Kenvue in a cash and stock deal for $48.7 billionNew York Post • 11/03/25
Kimberly-Clark to buy embattled Tylenol maker Kenvue in a deal valued at more than $48 billionMarket Watch • 11/03/25
Tylenol maker Kenvue misses sales estimates amid Kimberly-Clark's $48.7-billion dealReuters • 11/03/25
Kimberly-Clark, Vertex And Other Big Stocks Moving Lower In Monday's Pre-Market SessionBenzinga • 11/03/25
KMB Stock Alert: Halper Sadeh LLC is Investigating Whether the Merger of Kimberly-Clark Corporation is Fair to ShareholdersBusiness Wire • 11/03/25
Kimberly-Clark agrees to buy Kenvue in $48.7 billion deal, creating consumer staples giantCNBC • 11/03/25
Kimberly-Clark to Acquire Kenvue, Creating a $32 Billion Global Health and Wellness LeaderPRNewsWire • 11/03/25
KMB Q3 Earnings Beat Estimates, Sales In Line With the Year-Ago LevelZacks Investment Research • 10/30/25
Kimberly-Clark (KMB) Reports Q3 Earnings: What Key Metrics Have to SayZacks Investment Research • 10/30/25
Kimberly-Clark beats quarterly sales estimates as demand holds for household staplesReuters • 10/30/25
Kimberly-Clark: Lowest P/E Since 2013, Everyone Should Consider This Defensive GemSeeking Alpha • 10/29/25